AOD-9604's side-effect picture is unusual among research peptides because it actually has pooled human safety data. Across six randomized, placebo-controlled trials totaling roughly 900 subjects, its safety and tolerability were largely indistinguishable from placebo, with no change in IGF-1 or glucose tolerance and no anti-drug antibodies reported.[1][2]
Reviewed for accuracy · Last reviewed July 7, 2026That relatively reassuring safety signal should be read alongside the weak efficacy signal: the same program did not show meaningful weight loss, so a clean tolerability profile is not the same as a useful drug. Reported real-world effects are mostly local, such as injection-site irritation. Because AOD-9604 is sold as a research chemical or supplement ingredient rather than an approved medicine, product purity remains a practical concern, and it is prohibited in drug-tested sport.
The pooled human data suggests few effects beyond placebo, so the practical basics (site rotation, watching for signs of infection or an allergic reaction) cover most of it. Athletes should note its WADA-prohibited status before use.
This page is an independent educational reference and is not medical advice, and does not indicate any approval status for any use. Talk to a doctor before starting any compound.